SEATTLE and TAMPA, Fla., Nov. 11, 2019 /PRNewswire/ -- WellCare Health Plans, Inc. (NYSE: WCG) has expanded its presence in the state of Washington, and during this year's Medicare Annual Election Period (AEP), running now through Dec. 7, 2019, Medicare-eligible beneficia

CONCORD, N.H. and TAMPA, Fla., Nov. 11, 2019 /PRNewswire/ -- WellCare Health Plans, Inc. (NYSE: WCG) has expanded its presence in New Hampshire, and during this year's Medicare Annual Election Period (AEP), running now through Dec. 7, 2019, Medicare-eligible beneficiaries

MINNEAPOLIS, Nov. 11, 2019 /PRNewswire/ -- John Mack, VP and general manager of Medtronic's Cardiac Surgery business, was elected chair of the American Heart Association's Twin Cities Board, for a two-year term. "We are honored to have John's expertise and leadership to guide us into the fut

NASHVILLE, Tenn., Nov. 11, 2019 /PRNewswire/ -- Tivity Health® (Nasdaq: TVTY), a leading provider of nutrition, fitness and social engagement solutions, will launch a meal delivery program in 2020 that will offer fully prepared meals specially designed by nutritionists to meet the dietary needs of older adults. Wisely Well™

ATLANTA, Nov. 11, 2019 /PRNewswire/ -- Holon Solutions, healthcare's leading data liberator, announced today it has selected healthcare IT veteran

NEW YORK, Nov. 11, 2019 /PRNewswire/ -- Today WW (NASDAQ: WW) - Weight Watchers Reimagined - launches myWW, a new program that is its most customized weight-loss program ever. Driven by science and behavioral insights, and offering more flexibility and freedom than ever before, myWW makes losing weight easier. myWW leverages details about food p

PORTLAND, Ore., Nov. 11, 2019 /PRNewswire/ -- Mercy, which serves patients across four states, will deploy Bright.md's asynchronous virtual care product to deliver the industry's premier patient-focused online care experience and improve patient convenience and access. Already a leader in virtual care delivery, Mercy will integrate Bright.md services into their care

SPRING HOUSE, Pa., Nov. 11, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced 24-week Phase 3 data showing a significantly greater proportion of patients with active psoriatic arthritis (PsA) treated with TREMFYA® (guselkumab) achieved at least a 20 percent improvement in disease signs and sympto

LEXINGTON, Mass., Nov. 11, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced today that it received $10M upfront for a License Agreement with UroGen Pharma Ltd. Un

BOSTON, Nov. 11, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that it will report third quarter 2019 financial results on Thursday, November